Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs
At issue is whether a drug developed by Point Biopharma, based in Indianapolis, infringed on a patent issued in 2020 and assigned to Purdue Research Foundation.
Health Care & Insurance
Articles
Surgeon general asks Congress to require warning labels for social media
Dr. Vivek Murthy said social media is a contributing factor in the mental health crisis among young people and should carry warning labels similar to those now mandatory on cigarette boxes.
Not-for-profits, anonymous donor pay off medical debt for 112,000
The debt-relief initiative is part of a partnership between the United Neighborhood Centers of Indianapolis, United Way of Central Indiana and national not-for-profit Undue Medical Debt.
Drug shortages keep growing. Older, injectable medicines among most vulnerable.
Total active shortages hit an all-time high of 323 in this year’s first quarter, according to the University of Utah Drug Information Service. That’s up about 86% since 2017.
Ascension St. Vincent says it has restored electronic records system hit by May cyberattack
Ascension, the largest Catholic health system in the United States, was hit May 8 by a cyberattack that hindered computer access across the system and affected patient care.
Researchers say money alone isn’t enough to overcome public health workforce woes
New research delves into hiring woes outside of low salaries, such as the lengthy bureaucratic process that can take up to 204 days to complete for federal public health jobs.
IU Health to eliminate noncompete clauses for primary-care docs
The move comes a year after the Indiana General Assembly passed a law banning noncompete clauses in new contracts for physicians practicing primary care. IU Health said it decided to extend the same benefit to physicians who are currently employed.
Senator’s letter critical of hospital association casts shadow on 2025 health care discussions
A high-ranking senator accused the state’s leading hospital lobbying organization of being “responsible for the gradual breakdown of trust” between lawmakers and hospital systems after the most recent legislative session.
Michigan’s largest insurer to drop weight-loss drug coverage
Obesity drugs such as Novo’s Wegovy and Lilly’s Zepbound are exploding in popularity. But with list prices of $1,000 a month or more, insurers are balking at the prices and trying to limit how widely they’re used.
U.S. consumer agency proposes to ban medical debt from credit reports, loan decisions
The rules would ban credit reporting agencies from incorporating medical debt when calculating credit scores. They would also bar lenders from using medical debt to determine loan eligibility.
Lilly hopes for positive FDA news on Alzheimer’s drug as stock sets new high
Lilly officials have said they are “incredibly confident” in the drug’s potential and the fact that it “offers very meaningful benefits to people with early symptomatic Alzheimer’s disease.”
Moderna’s flu-COVID combo shot hits goal in late-stage trial
The company is one step closer to a more convenient jab that could help combat vaccine fatigue.
FDA reverses ban on Juul products as Supreme Court decision awaits
The FDA said Thursday that the move to rescind the ban was made in light of court cases involving the vaping industry and because the agency has since “gained more experience” with scientific issues involving e-cigarette products.
Indiana joins 14 states in lawsuit challenging federal protections for transgender care
Indiana Attorney General Todd Rokita’s office said covered entities that fail to follow the HHS rule risk the loss of significant federal funding—including Medicaid funding designed to assist low-income individuals.
Lilly CFO Ashkenazi leaving to take job at Google parent Alphabet
Anat Ashkenazi was Lilly’s third-highest paid executive last year. She has worked at the company for 23 years, including as chief financial officer since 2021.
Britain poised to offer Eli Lilly’s weight-loss drug to patients
If the guidance is confirmed, Mounjaro will challenge the dominance of Novo’s Wegovy in the United Kingdom.
New director for IU Indy bioscience institute sets precision medicine as major goal
James Lin, a biomedical researcher who has focused on new innovations for tissue engineering and regenerative medicine, will start his new job in Indianapolis on Aug. 26.
Community Health planning $335M hospital in Westfield
The 425,000-square-foot project will mark the Indianapolis-based health care system’s first hospital in Hamilton County.
In the pandemic, we were told to keep 6 feet apart. There’s no science to support that.
Congressional investigators are set Monday to press Dr. Anthony Fauci on why the CDC’s recommendation was allowed to shape so much of American life for so long, particularly given Fauci and other officials’ recent acknowledgments that there was no science behind the six-foot rule after all.
Weight-loss drug shortages lead to tracker from startup
Ro’s tracker is the latest in the frenzy surrounding weight-loss drugs made by Novo Nordisk and Indianapolis-based Eli Lilly and Co.